Motor Imagery Training in Persons With Multiple Sclerosis
Launched by DOKUZ EYLUL UNIVERSITY · May 19, 2016
Trial Information
Current as of May 17, 2025
Completed
Keywords
ClinConnect Summary
Multiple sclerosis (MS) is a chronic, inflammatory, and demyelinating disease of the central nervous system. It is the most common neurological disease which causes progressive gait and balance disorders in young adults. The previous studies have indicated that home care and treatment services, which accelerates the healing process and makes the one feel better, are more preferred by the patients. Persons with MS are commonly not able to access the institutional rehabilitation services because of their disability and/or home location. It restricts the participation of the persons with MS an...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of multiple sclerosis
- • Having the Expanded Disability Status Scale 0 - 4.0
- • Relapse-free period at the last 3 months
- • Enough computer use ability
- • Having computer and internet connection
- Exclusion Criteria:
- • Having severe musculoskeletal, cardiovascular, pulmonary, or metabolic disease
- • Severe cognitive impairment
- • Pregnancy
About Dokuz Eylul University
Dokuz Eylul University is a prominent educational institution located in İzmir, Turkey, recognized for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to conduct cutting-edge research aimed at improving patient outcomes. With a focus on interdisciplinary collaboration and adherence to ethical standards, Dokuz Eylul University strives to contribute valuable insights to the medical community while fostering the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Izmir, , Turkey
Izmir, , Turkey
Patients applied
Trial Officials
Sema Savci, Prof, PhD
Study Director
Dokuz Eylul University
Turhan Kahraman, MSc
Principal Investigator
Dokuz Eylul University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials